Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson’s disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group study (CONST-PD)
Taku Hatano, Genko Oyama, Yasushi Shimo, Kotaro Ogaki, Noriko Nishikawa, Jiro Fukae, Ryota Nakamura, Naohide Kurita, Taiji Tsunemi, Yutaka Oji, Shinji Saiki, Kenya Nishioka, Haruka Takeshige-Amano, Daisuke Taniguchi, Takashi Ogawa, Hikaru Kamo, Hiroto Eguchi, Atsuhito Fuse, Asuka Nakajima, Masayoshi Kano, Sho Nakajima, Naotake Yanagisawa, Nobutaka Hattori
BMJ Open Feb 2022, 12 (2) e054129; DOI: 10.1136/bmjopen-2021-054129
